Panacea Biotec has informed that it has enclosed a certificate dated July 15, 2019, issued by Skyline Financial Services, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2019.
The above information is a part of company’s filings submitted to BSE.